89Bio Inc. held its 2025 Annual Meeting of Stockholders on May 28, 2025. During the meeting, all director nominees were elected, and the proposal to ratify KPMG LLP as the independent auditor was approved. Additionally, the advisory vote on executive compensation received approval.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.